Emerging research suggest Retatrutide , a dual agonist targeting both the gut-brain axis and GIP , appears to provide a significant advancement for body loss . Initial clinical investigations have https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026